GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Olipass Corp (XKRX:244460) » Definitions » Interest and Commission Paid

Olipass (XKRX:244460) Interest and Commission Paid


View and export this data going back to 2019. Start your Free Trial

What is Olipass Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Olipass Business Description

Industry
Traded in Other Exchanges
N/A
Address
16-4, 16 Beon-gil, Dongbaek Jungang-ro, Ace Dongbaek Tower 20th Floor, Giheung-gu, Yongin, KOR, 17015
Olipass Corp is a South Korea based biotechnology company engaged in developing its platform OliPass PNA which focuses on introducing cationic lipid moiety onto nucleobase. Its pipeline products include SC Injection, Hyper Cholesterolemia, Chemo/Radio-sensitizer, and Type II Diabetes among others.